Annual Long Term Debt
$10.55 M
-$1.21 M-10.27%
December 31, 2022
Summary
- As of February 10, 2025, NLTX annual long term debt is $10.55 million, with the most recent change of -$1.21 million (-10.27%) on December 31, 2022.
- During the last 3 years, NLTX annual long term debt has risen by +$9.96 million (+1679.93%).
Performance
NLTX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Debt
$9.14 M
-$410.00 K-4.29%
September 30, 2023
Summary
- As of February 10, 2025, NLTX quarterly long term debt is $9.14 million, with the most recent change of -$410.00 thousand (-4.29%) on September 30, 2023.
- Over the past year, NLTX quarterly long term debt has dropped by -$1.55 million (-14.52%).
Performance
NLTX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
NLTX Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.3% | -14.5% |
| 3 y3 years | +1679.9% | -20.2% |
| 5 y5 years | +10000.0% | +10000.0% |
NLTX Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.3% | at low | -22.3% | at low |
| 5 y | 5-year | -10.3% | -94.4% | -28.2% | -93.5% |
| alltime | all time | -10.3% | -99.9% | -28.2% | -99.9% |
Neoleukin Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $9.14 M(-4.3%) |
| Jun 2023 | - | $9.55 M(-4.0%) |
| Mar 2023 | - | $9.95 M(-5.8%) |
| Dec 2022 | $10.55 M(-10.3%) | $10.55 M(-1.3%) |
| Sep 2022 | - | $10.69 M(-3.2%) |
| Jun 2022 | - | $11.04 M(-3.5%) |
| Mar 2022 | - | $11.44 M(-2.8%) |
| Dec 2021 | $11.76 M(+3.1%) | $11.76 M(-2.6%) |
| Sep 2021 | - | $12.07 M(-2.4%) |
| Jun 2021 | - | $12.37 M(-2.8%) |
| Mar 2021 | - | $12.73 M(+11.5%) |
| Dec 2020 | $11.41 M(+1824.8%) | $11.41 M(-0.4%) |
| Sep 2020 | - | $11.46 M(+11.2%) |
| Jun 2020 | - | $10.30 M(-0.2%) |
| Mar 2020 | - | $10.33 M(+1641.7%) |
| Dec 2019 | $593.00 K | $593.00 K(+68.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $351.00 K(+37.6%) |
| Jun 2019 | - | $255.00 K(-13.9%) |
| Mar 2019 | - | $296.00 K(+4833.3%) |
| Dec 2018 | $6000.00(-81.8%) | $6000.00(-40.0%) |
| Sep 2018 | - | $10.00 K(-58.3%) |
| Jun 2018 | - | $24.00 K(-14.3%) |
| Mar 2018 | - | $28.00 K(-15.2%) |
| Dec 2017 | $33.00 K(-29.8%) | $33.00 K(-10.8%) |
| Sep 2017 | - | $37.00 K(-7.5%) |
| Jun 2017 | - | $40.00 K(-9.1%) |
| Mar 2017 | - | $44.00 K(-6.4%) |
| Dec 2016 | $47.00 K(+571.4%) | $47.00 K(+80.8%) |
| Sep 2016 | - | $26.00 K(+271.4%) |
| Jun 2016 | - | $7000.00(0.0%) |
| Mar 2016 | - | $7000.00(0.0%) |
| Dec 2015 | $7000.00(-99.7%) | $7000.00(-99.7%) |
| Dec 2013 | $2.04 M | $2.04 M |
FAQ
- What is Neoleukin Therapeutics annual long term debt?
- What is the all time high annual long term debt for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics annual long term debt year-on-year change?
- What is Neoleukin Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics quarterly long term debt year-on-year change?
What is Neoleukin Therapeutics annual long term debt?
The current annual long term debt of NLTX is $10.55 M
What is the all time high annual long term debt for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high annual long term debt is $11.76 M
What is Neoleukin Therapeutics annual long term debt year-on-year change?
Over the past year, NLTX annual long term debt has changed by -$1.21 M (-10.27%)
What is Neoleukin Therapeutics quarterly long term debt?
The current quarterly long term debt of NLTX is $9.14 M
What is the all time high quarterly long term debt for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high quarterly long term debt is $12.73 M
What is Neoleukin Therapeutics quarterly long term debt year-on-year change?
Over the past year, NLTX quarterly long term debt has changed by -$1.55 M (-14.52%)